HOME >> MEDICINE >> NEWS
New highly active agents against sandfly fever

Leishmaniases and trypanosomiases are parasitic diseases which kill several thousands of people per year, mainly in developing countries. The effectiveness of existing treatments is being called into question owing to their toxicity and the emergence of resistance. A family of alkaloids, the quinolines, could be a worthwhile new therapeutic line to follow. Following on from the discovery of anti-leishmaniasis activity in natural quinolines, a research team of IRD, Pasteur Institute and CNRS scientists(1) carried out investigations on this chemical family. Some of the many quinolines synthesized in the laboratory have antiparasitic properties, especially against leishmaniases, others have antiretroviral activity. Biological trials in the mouse have already confirmed their properties and therapeutic efficacy.

Parasitic diseases, especially leishmaniases and trypanosomiases, kill hundreds of thousands of people every year in the world, mainly in the countries of the South. The most severe form of leishmaniosis (kala-azar, the visceral form), induced by Leishmania donovani and L. infantum, affects about 500 000 people per year and proves fatal if no treatment is given.

Although drugs do exist for treating these diseases, they are not always effective, owing to the appearance of resistant parasites and to the toxicity of the products. Moreover, administration of the available treatments against leishmaniases is mainly by injection, which means that patients have to go to hospital. Most people infected live in areas either far from health-care facilities or completely devoid of them. Research for new substances with potential as therapeutic agents is consequently necessary.

IRD researchers conducted ethno-pharmacological studies in line with this search, in South America. These scientists, working with researchers from the CNRS, the University of Paris-Sud and the Institut Pasteur (1), have thus discovered and studied alkaloids of the c
'"/>

Contact: Hlne Deval
presse@paris.ird.fr
33-148-037-519
Institut de Recherche Pour le Dveloppement
14-Feb-2005


Page: 1 2 3

Related medicine news :

1. Engineers develop biowarfare sensing elements for future highly sensitive nerve-gas detectors
2. Patients with cancer have highly increased risk for blood clots
3. Inflammatory cells highly promising target in NF 1
4. Multi-center study finds therapy boosts kidney transplants in highly sensitized patients
5. Columbia Univ. Medical Center wins highly competitive stroke grant from NIH
6. Study showed vitamin D inadequacy highly prevalent among women treated for osteoporosis
7. World mental health surveys find mental disorders highly prevalent and often untreated
8. MRI highly useful in the evaluation of patients with uterine fibroids
9. 1st data show CRESTOR highly effective at lowering LDL-C in patients with type 2 diabetes
10. One in five asthmatics are highly sensitive to aspirin
11. New data show botulinum toxin type A to be highly effective treatment for excessive sweating

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New highly active agents against sandfly fever

(Date:5/25/2013)... York, New York (PRWEB) May 25, 2013 ... federal multidistrict litigation underway in U.S. District Court, Western ... LLP reports. According to a Case Management Order ... that govern the filing of contested motions in the ... filing those motions. (In re: Actos Product Liability Litigation, ...
(Date:5/25/2013)... Radius Engineering International Inc., is ... the US and has been building concrete, steel, ... years. M.E. and President, Walton McCarthy, author of ... Fundamentals and Shelter Engineering Standards, Sixth Edition, 2012, ... engineering. McCarthy is considered the leading expert in ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 On May 20, ... people do not wish to discuss or plan for their ... FuneralFinancials.com released a Must-Do List to help ... Funeral Financials recommends, “Creating a personal fact sheet.” , While ... organize financial information and personal data. It may include ...
(Date:5/25/2013)... On May 25, Voices Against Brain ... advocacy, comments on a new study by the Max ... atmospheric plasma into brain cancer treatment may help when ... Science Daily article, physicists from the Max ... demonstrated the “synergistic effect of cold atmospheric plasma -- ...
(Date:5/25/2013)... Vancouver, BC (PRWEB) May 25, 2013 ... of the most beautiful and powerful women that ever ... was felt by some of the most powerful men ... used many beauty remedies to keep her skin glowing ... treatments made with bees- wax, maringa oil and cyprus ...
Breaking Medicine News(10 mins):Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3
(Date:5/24/2013)... HAYWARD, Calif. , May 24, 2013 Solta ... in the medical aesthetics market, today reported Dr. ... of the Company,s Board of Directors effective immediately.  Dr. Knowlton ... Medical and had served as a director since 1996. ... well as our management team, I would like to thank ...
(Date:5/24/2013)... , May 24, 2013  Auxilium Pharmaceuticals, Inc. ... management will participate in the Deutsche Bank Health Care ... Boston Waterfront Hotel.  Mr. Adrian Adams ... present an overview of the Company and its product ... 2013.   (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) ...
(Date:5/24/2013)... England and BOSTON , ... GPCR drug discovery and development company, is pleased to announce that ... a Consultant to augment the Company,s business development capabilities in ... Usui has more than 15 years of experience in business development, ... at Perlegen Sciences, Inc., Roche Pharma ( Japan ), ...
Breaking Medicine Technology:Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2
Cached News: